Blair William & CO Nektar Therapeutics Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Nektar Therapeutics stock. As of the latest transaction made, Blair William & CO holds 12,944 shares of NKTR stock, worth $12,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,944

Previous 12,944 -0.0%

Holding current value

$12,037

Previous $16,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.9 - $1.83 $286 - $581	-318 Reduced 2.4%	12,944 $16,000
Q1 2024 May 09, 2024	SELL	$0.49 - $0.96 $132 - $259	-270 Reduced 2.0%	13,262 $12,000
Q4 2023 Feb 12, 2024	SELL	$0.42 - $0.57 $10,294 - $13,970	-24,510 Reduced 64.43%	13,532 $7,000
Q3 2023 Nov 09, 2023	SELL	$0.51 - $1.05 $455 - $938	-894 Reduced 2.3%	38,042 $22,000
Q1 2023 May 12, 2023	SELL	$0.64 - $3.15 $1,184 - $5,827	-1,850 Reduced 4.54%	38,936 $27,000
Q4 2022 Feb 10, 2023	SELL	$2.03 - $4.28 $236,275 - $498,157	-116,392 Reduced 74.05%	40,786 $92,000
Q3 2022 Nov 09, 2022	SELL	$3.04 - $5.14 $54,039 - $91,368	-17,776 Reduced 10.16%	157,178 $503,000
Q2 2022 Aug 10, 2022	SELL	$3.17 - $6.17 $180,965 - $352,226	-57,087 Reduced 24.6%	174,954 $665,000
Q1 2022 May 13, 2022	SELL	$4.16 - $13.72 $1.32 Million - $4.34 Million	-316,232 Reduced 57.68%	232,041 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $1.03 Million - $1.75 Million	-95,200 Reduced 14.79%	548,273 $7.41 Million
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $3.17 Million - $4.57 Million	242,771 Added 60.59%	643,473 $11.6 Million
Q2 2021 Aug 12, 2021	SELL	$16.52 - $20.4 $1.69 Million - $2.08 Million	-102,011 Reduced 20.29%	400,702 $6.88 Million
Q1 2021 May 13, 2021	BUY	$16.56 - $25.46 $3.93 Million - $6.03 Million	237,033 Added 89.22%	502,713 $10.1 Million
Q4 2020 Feb 09, 2021	SELL	$15.77 - $19.03 $145,825 - $175,970	-9,247 Reduced 3.36%	265,680 $4.52 Million
Q3 2020 Nov 06, 2020	BUY	$16.59 - $24.79 $219,618 - $328,170	13,238 Added 5.06%	274,927 $4.56 Million
Q2 2020 Aug 12, 2020	BUY	$16.86 - $23.44 $234,826 - $326,472	13,928 Added 5.62%	261,689 $6.06 Million
Q1 2020 May 11, 2020	SELL	$14.47 - $27.96 $563,317 - $1.09 Million	-38,930 Reduced 13.58%	247,761 $4.42 Million
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $158 - $231	10 Added 0.0%	286,691 $6.19 Million
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $711,420 - $1.53 Million	42,071 Added 17.2%	286,681 $5.22 Million
Q2 2019 Aug 13, 2019	BUY	$31.0 - $36.3 $644,862 - $755,112	20,802 Added 9.29%	244,610 $8.7 Million
Q1 2019 May 14, 2019	BUY	$31.58 - $46.35 $382,654 - $561,622	12,117 Added 5.72%	223,808 $7.52 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $299,826 - $558,172	9,853 Added 4.88%	211,691 $6.96 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $95,893 - $141,363	2,064 Added 1.03%	201,838 $12.3 Million
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $315,240 - $711,931	6,816 Added 3.53%	199,774 $9.76 Million
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $8.22 Million - $15.5 Million	-143,150 Reduced 42.59%	192,958 $20.5 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $357,661 - $939,988	-15,537 Reduced 4.42%	336,108 $20.1 Million
Q3 2017 Nov 13, 2017	BUY	$17.79 - $24.0 $6.26 Million - $8.44 Million	351,645	351,645 $8.44 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account